BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25283513)

  • 21. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a.
    Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y
    Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.
    Gill H; Yim R; Lee HKK; Mak V; Lin SY; Kho B; Yip SF; Lau JSM; Li W; Ip HW; Hwang YY; Chan TSY; Tse E; Au WY; Kumana CR; Kwong YL
    Cancer; 2018 Jun; 124(11):2316-2326. PubMed ID: 29579321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
    Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
    J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SnoN/SkiL, a TGFβ signaling mediator: a participant in autophagy induced by arsenic trioxide.
    Raffoul F; Campla C; Nanjundan M
    Autophagy; 2010 Oct; 6(7):955-7. PubMed ID: 20699661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.
    Mishra S; Deng JJ; Gowda PS; Rao MK; Lin CL; Chen CL; Huang T; Sun LZ
    Oncogene; 2014 Jul; 33(31):4097-106. PubMed ID: 24037531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
    Kumagai T; Ikezoe T; Gui D; O'Kelly J; Tong XJ; Cohen FJ; Said JW; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(4):1508-20. PubMed ID: 14977855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.
    Gill H; Kumana CR; Yim R; Hwang YY; Chan TSY; Yip SF; Lee HKK; Mak V; Lau JSM; Chan CC; Kho B; Wong RSM; Li W; Lin SY; Lau CK; Ip HW; Leung RYY; Lam CCK; Kwong YL
    Cancer; 2019 Sep; 125(17):3001-3012. PubMed ID: 31090936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
    Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
    Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunofluorescence examination of CK-13 expression in cell line KB differentiated by all-trans retinoic acid or As2 O3].
    Zhao XH; Zhu HJ; Lu DP; Zhang M
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jan; 44(1):53-5. PubMed ID: 19489262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
    Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
    Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
    Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
    Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo.
    Li Y; Jiang F; Chen L; Yang Y; Cao S; Ye Y; Wang X; Mu J; Li Z; Li L
    FEBS Open Bio; 2015; 5():466-75. PubMed ID: 26106521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
    Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.
    Jadhav V; Ray P; Sachdeva G; Bhatt P
    Life Sci; 2016 Mar; 148():41-52. PubMed ID: 26883975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.
    Yan W; Chen X; Zhang Y; Zhang J; Jung YS; Chen X
    J Biol Chem; 2013 Feb; 288(5):2907-13. PubMed ID: 23271742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.